President Piñera begins the vaccination against Covid-19 for older adults.
Sebastián Piñera · President of Chile
- Context
- Piñera launched Chile's COVID-19 vaccination campaign for elderly residents in long-term care facilities on January 18, 2021.
- Main themes
- COVID-19 vaccination rollout, elderly and high-risk population protection, vaccination targets and timeline, Pfizer-BioNTech and Sinovac vaccines, long-term care facilities, public health urgency
- Duration
- ~1 min
- Words
- 136
- Sentences
- 6
- Readability
- 48
- Grade
- 11.8
- Syntax
- 3.65
- Vocabulary
- 2.16
Translated from Spanish
The broad sphere of national life a sentence belongs to. Every sentence has an Arena, so it is the denominator the other indices are read against.
Other6 sentences in 5 paragraphs
Today, with Mrs. Laura, we began the vaccination process for our elderly residents living in Long-Term Care Facilities.
This is very important because the elderly, just like those with chronic illnesses, constitute a high-risk population; we must protect them with great care and urgency.
And starting today, the process will not stop. As new shipments of the Pfizer-BioNTech vaccine arrive, and soon the Sinovac or AstraZeneca vaccine, we will continue vaccinating the entire population, starting with those who are at the highest risk.
Our plan is to vaccinate the majority of the high-risk population, nearly 5 million people, during the first quarter and to vaccinate a large part of the target population, around 15 million people, during the first half of the year.
It is a formidable challenge, but with your help, we will achieve it.
The original Spanish. The tags above are read on the English translation's sentences.
Hoy con la señora Laura iniciamos el proceso de vacunación de nuestros adultos mayores que viven en los Establecimientos de Larga Estadía.
Esto es muy importante porque los adultos mayores igual que los enfermos crónicos constituyen una población de riesgo, tenemos que protegerlos con mucho cariño y con mucha urgencia.
Y a partir de hoy el proceso no se detiene. A medida que vayan llegando los nuevos embarques de la vacuna Pfizer-BioNTech y prontamente la vacuna Sinovac o la vacuna AstraZeneca vamos a ir vacunando a toda la población, empezando por los que representan un mayor riesgo.
Nuestro plan es vacunar al grueso de la población de alto riesgo, cerca de 5 millones de personas, durante el primer trimestre y vacunar a gran parte de la población objetivo, cerca de 15 millones de personas, durante el primer semestre.
Es un desafío formidable, pero con su ayuda, lo vamos a lograr.